Depatuxizumab mafodotin for treating recurrent EGFR-amplified glioblastoma [ID1244]
Discontinued
Reference number: GID-TA10242
Please note this scoping exercise has now been suspended pending confirmation of trial reporting and regulatory submission timelines. Please do not submit comments on this topic. We apologise for any inconvenience this may cause.